Takeda Pharmaceutical Co. agreed to a $2.4 billion settlement to resolve bladder cancer claims tied to its Type 2 diabetes drug Actos. On past Ringler Radio shows, we have followed the litigation surrounding Actos.  On Ringler Radio, host Larry Cohen and co-host, Keith Christie join guest Attorney Frank Woodson, from the Beasley Allen Law Firm,  to discuss this billion dollar settlement, negotiating a settlement and the impact on future pharmaceutical litigation.

Visit Ringler to contact a consultant in your area about structured settlements.

A jury determined that drug makers hid cancer risks associated with the diabetes medicine, Actos, from the public. Complications stemming from transvaginal mesh and lawsuits by women against the manufacturers is another case of how a defective product can have a huge impact on a life.  Zohydro, a controversial painkiller is making waves when it comes to prescription drug abuse. On this Ringler Radio podcast, host Larry Cohen joins Andy Birchfield and Leigh O’Dell from the Beasley Allen Law Firm, as they spotlight litigation in these cases, causing a stir across the States.

Visit Ringler to contact a consultant in your area about structured settlements.

The Type II Diabetes drug, Actos has received a black box label, has had a label change warning of a 40% increase in the risk for bladder cancer, and has been banned in France and Germany.  Yet, Actos still remains on the market in the United States.  Ringler Radio, host Larry Cohen joins colleague Martin C. Blount and Attorney Michael J. Miller, from The Miller Firm LLC, to discuss the side effects of the diabetes medication Actos, including its connection to bladder cancer, reaction of the FDA, and recent litigation.

Visit Ringler to contact a consultant in your area about structured settlements.